Beat the S&P 500 With This Cash-Gushing Dividend Stock
Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb (NYSE: BMY). At the time of writing, shares of the healthcare giant have climbed 4% year to date -- a notable outlier amid the broader stock market sell-off, with the S&P 500 index currently down nearly 10% from its peak.Better-than-expected financial results in recent quarters have signaled an improved outlook, helping to sustain the rally. Even more appealing is Bristol Myers Squibb's 4% dividend yield, making it an excellent choice for investors seeking regular portfolio income.Here's why this cash-generating biopharmaceutical leader is poised to continue outperforming the S&P 500.Continue reading
Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb (NYSE: BMY). At the time of writing, shares of the healthcare giant have climbed 4% year to date -- a notable outlier amid the broader stock market sell-off, with the S&P 500 index currently down nearly 10% from its peak.
Better-than-expected financial results in recent quarters have signaled an improved outlook, helping to sustain the rally. Even more appealing is Bristol Myers Squibb's 4% dividend yield, making it an excellent choice for investors seeking regular portfolio income.
Here's why this cash-generating biopharmaceutical leader is poised to continue outperforming the S&P 500.
